{"denoms":[{"counts":[{"groupId":"BG000","value":"54"}],"units":"Participants"}],"groups":[{"id":"BG000","title":"Anakinra With/Without Dexamethasone"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"38","upperLimit":"79","value":"60.0"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"29"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"54"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"44"}]}],"title":"Smoldering Multiple Myeloma (SMM)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"Indolent Multiple Myeloma (IMM)"}],"paramType":"NUMBER","title":"Diagnosis","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"44"}]}],"title":"No"}],"paramType":"NUMBER","title":"Prior treatment for M-protein","unitOfMeasure":"participants"}]}